Bereich
Rheumatologie
RHEUMA · Dept. I
Pulmonale Infiltrate als Erstmanifestation einer Polyarteriitis nodosa (PAN).
Schmiedeberg K, Rottländer Y, von Kempis J, Rubbert-Roth A, Den Hollander J. Pulmonale Infiltrate als Erstmanifestation einer Polyarteriitis nodosa (PAN). - Manifestationen der Polyarteriitis nodosa. Rheuma Schweiz 2024; 1:5-146-150.
02.12.2024Pulmonale Infiltrate als Erstmanifestation einer Polyarteriitis nodosa (PAN).
02.12.2024Rheuma Schweiz 2024; 1:5-146-150
Schmiedeberg Kristin, Rottländer Yella, von Kempis Johannes, Rubbert-Roth Andrea, Den Hollander Jürgen
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors.
Sorin B, Papo M, Sinico R, Teixeira V, Venhoff N, Urban M, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Feder C, Kroegel C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn J, Bonnotte B, Durel C, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Porcher R, Terrier B. Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors. J Autoimmun 2024; 149:103338.
16.11.2024Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors.
16.11.2024J Autoimmun 2024; 149:103338
Sorin Boris, Papo Matthias, Sinico Renato Alberto, Teixeira Vítor Silvestre, Venhoff Nils, Urban Maria Letizia, Iudici Michele, Mahrhold Juliane, Locatelli Francesco, Cassone Giulia, Schiavon Franco, Seeliger Benjamin, Neumann Thomas, Feder Claudia, Kroegel Claus, Groh Matthieu, Marvisi Chiara, Samson Maxime, Barba Thomas, Jayne David R.W., Troilo Arianna, Thiel Jens, Hellmich Bernhard, Monti Sara, Montecucco Carlomaurizio, Salvarani Carlo, Kahn Jean-Emmanuel, Bonnotte Bernard, Durel Cécile-Audrey, Puéchal Xavier, Mouthon Luc, Guillevin Loic, Emmi Giacomo, Vaglio Augusto, Porcher Raphael, Terrier Benjamin
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study.
Fleischmann R, Meerwein S, Charles-Schoeman C, Combe B, Hall S, Khan N, Carter K, Camp H, Rubbert-Roth A. Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study. RMD Open 2024; 10
25.07.2024Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study.
25.07.2024RMD Open 2024; 10
Fleischmann Roy, Meerwein Sebastian, Charles-Schoeman Christina, Combe Bernard, Hall Stephen, Khan Nasser, Carter Kyle M, Camp Heidi S, Rubbert-Roth Andrea
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.
Rubbert-Roth A, Kato K, Haraoui B, Rischmueller M, Liu Y, Khan N, Camp H, Xavier R. Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study. Rheumatol Ther 2024; 11:1197-1215.
20.07.2024Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.
20.07.2024Rheumatol Ther 2024; 11:1197-1215
Rubbert-Roth Andrea, Kato Koji, Haraoui Boulos, Rischmueller Maureen, Liu Yanxi, Khan Nasser, Camp Heidi S, Xavier Ricardo M
Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners.
Joos L, Gonzalez Chiappe S, Neumann T, Mahr A. Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners. Rheumatol Int 2024; 44:3099-3106.
27.06.2024Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners.
27.06.2024Rheumatol Int 2024; 44:3099-3106
Joos Lukas, Gonzalez Chiappe Solange, Neumann Thomas, Mahr Alfred
Arthritis, Enthesitis und Muskelatrophie in Folge einer Kniedistorsion als initiale Präsentation einer Psoriasisarthritis sine psoriase.
Vetterli A, Schmiedeberg K, Dietrich T, Schilg-Hafer L. Arthritis, Enthesitis und Muskelatrophie in Folge einer Kniedistorsion als initiale Präsentation einer Psoriasisarthritis sine psoriase. Rheuma Schweiz 2024; 1:4-56-59.
13.06.2024Arthritis, Enthesitis und Muskelatrophie in Folge einer Kniedistorsion als initiale Präsentation einer Psoriasisarthritis sine psoriase.
13.06.2024Rheuma Schweiz 2024; 1:4-56-59
Vetterli Andrea, Schmiedeberg Kristin, Dietrich Tobias, Schilg-Hafer Lenka
EXPRESSION ON MONOCYTES IN URINE THAN ON MONOCYTES IN PERIPHERAL BLOOD INDICATES SEVERITY OF RENAL INVOLVEMENT IN SLE PATIENT
Attar A, Böni L, Schmiedeberg K, Bürgi J, Rubbert-Roth A, von Kempis J (2024). EXPRESSION ON MONOCYTES IN URINE THAN ON MONOCYTES IN PERIPHERAL BLOOD INDICATES SEVERITY OF RENAL INVOLVEMENT IN SLE PATIENT.
12.06.2024EXPRESSION ON MONOCYTES IN URINE THAN ON MONOCYTES IN PERIPHERAL BLOOD INDICATES SEVERITY OF RENAL INVOLVEMENT IN SLE PATIENT
12.06.2024Euloar 2024
Attar A. A., Böni L., Schmiedeberg Kristin, Bürgi Justus J, Rubbert-Roth Andrea, von Kempis Johannes
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.
Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie S, Vaglio A, Castañeda S, Solans R, Mestre-Torres J, Khalidi N, Langford C, Ytterberg S, Beretta L, Govoni M, Emmi G, Cimmino M, Witte T, Neumann T, Holle J, Schoenau V, Pugnet G, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos A, Voskuyl A, Daikeler T, Berger C, Molloy E, Blockmans D, van Sleen Y, Iles M, Sorensen L, Luqmani R, Reynolds G, Bukhari M, Bhagat S, Ortego-Centeno N, Brouwer E, Lamprecht P, Klapa S, Salvarani C, Merkel P, Cid M, González-Gay M, Morgan A, Martin-Broto J, Márquez A, Spanish GCA Group, UK GCA Consortium, Vasculitis Clinical Research Consortium. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. Lancet Rheumatol 2024; 6:e374-e383.
08.05.2024Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.
08.05.2024Lancet Rheumatol 2024; 6:e374-e383
Borrego-Yaniz Gonzalo, Ortiz-Fernández Lourdes, Madrid-Paredes Adela, Kerick Martin, Hernández-Rodríguez José, Mackie Sarah L, Vaglio Augusto, Castañeda Santos, Solans Roser, Mestre-Torres Jaume, Khalidi Nader, Langford Carol A, Ytterberg Steven, Beretta Lorenzo, Govoni Marcello, Emmi Giacomo, Cimmino Marco A, Witte Torsten, Neumann Thomas, Holle Julia U, Schoenau Verena, Pugnet Gregory, Papo Thomas, Haroche Julien, Mahr Alfred, Mouthon Luc, Molberg Øyvind, Diamantopoulos Andreas P, Voskuyl Alexandre, Daikeler Thomas D, Berger Christoph T, Molloy Eamonn S, Blockmans Daniel, van Sleen Yannick, Iles Mark, Sorensen Louise, Luqmani Raashid A, Reynolds Gary, Bukhari Marwan, Bhagat Shweta, Ortego-Centeno Norberto, Brouwer Elisabeth, Lamprecht Peter, Klapa Sebastian, Salvarani Carlo, Merkel Peter A, Cid María C, González-Gay Miguel A, Morgan Ann W, Martin-Broto Javier, Márquez Ana, Spanish GCA Group, UK GCA Consortium, Vasculitis Clinical Research Consortium
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
Burmester G, Stigler J, Rubbert-Roth A, Tanaka Y, Azevedo V, Coombs D, Lagunes I, Lippe R, Wung P, Gensler L. Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials. Rheumatol Ther 2024; 11:737-753.
29.04.2024Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
29.04.2024Rheumatol Ther 2024; 11:737-753
Burmester Gerd R, Stigler Jayne, Rubbert-Roth Andrea, Tanaka Yoshiya, Azevedo Valderilio F, Coombs Derek, Lagunes Ivan, Lippe Ralph, Wung Peter, Gensler Lianne S
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Rech J, Taşçilar K, Hagen M, Kleyer A, Manger B, Schoenau V, Hueber A, Kleinert S, Baraliakos X, Braun J, Kiltz U, Fleck M, Rubbert-Roth A, Kofler D, Behrens F, Feuchtenberger M, Zaenker M, Voll R, Venhoff N, Thiel J, Glaser C, Feist E, Burmester G, Karberg K, Strunk J, Cañete J, Senolt L, Filkova M, Naredo E, Largo R, Krönke G, D'Agostino M, Østergaard M, Schett G. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet 2024; 403:850-859.
13.02.2024Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
13.02.2024Lancet 2024; 403:850-859
Rech Juergen, Taşçilar Koray, Hagen Melanie, Kleyer Arnd, Manger Bernhard, Schoenau Verena, Hueber Axel J, Kleinert Stefan, Baraliakos Xenofon, Braun Jürgen, Kiltz Uta, Fleck Martin, Rubbert-Roth Andrea, Kofler David M, Behrens Frank, Feuchtenberger Martin, Zaenker Michael, Voll Reinhard E, Venhoff Nils, Thiel Jens, Glaser Cornelia, Feist Eugen, Burmester Gerd R, Karberg Kirsten, Strunk Johannes, Cañete Juan D, Senolt Ladislav, Filkova Maria, Naredo Esperanza, Largo Raquel, Krönke Gerhard, D'Agostino Maria-Antonietta, Østergaard Mikkel, Schett Georg
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry.
Ciurea A, Götschi A, Bräm R, Bürki K, Exer P, Andor M, Nissen M, Möller B, Hügle T, Rubbert-Roth A, Kyburz D, Distler O, Scherer A, Micheroli R. Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry. RMD Open 2023; 9
01.12.2023Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry.
01.12.2023RMD Open 2023; 9
Ciurea Adrian, Götschi Andrea, Bräm René, Bürki Kristina, Exer Pascale, Andor Michael, Nissen Michael J, Möller Burkhard, Hügle Thomas, Rubbert-Roth Andrea, Kyburz Diego, Distler Oliver, Scherer Almut, Micheroli Raphael
Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis.
Rubbert-Roth A, Kakehasi A, Takeuchi T, Schmalzing M, Palac H, Coombs D, Liu J, Anyanwu S, Lippe R, Curtis J. Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis. Rheumatol Ther 2023; 11:97-112.
20.11.2023Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis.
20.11.2023Rheumatol Ther 2023; 11:97-112
Rubbert-Roth Andrea, Kakehasi Adriana M, Takeuchi Tsutomu, Schmalzing Marc, Palac Hannah, Coombs Derek, Liu Jianzhong, Anyanwu Samuel I, Lippe Ralph, Curtis Jeffrey R
Worse cardiovascular and renal outcome in male SLE patients.
Mihailovic J, Ribi C, Chizzolini C, Trendelenburg M, von Kempis J, Dahdal S, Huynh-Do U, Swiss Systemic Lupus Erythematosus Cohort Study Group (SSCS). Worse cardiovascular and renal outcome in male SLE patients. Sci Rep 2023; 13:18628.
30.10.2023Worse cardiovascular and renal outcome in male SLE patients.
30.10.2023Sci Rep 2023; 13:18628
Mihailovic Jelena, Ribi Camillo, Chizzolini Carlo, Trendelenburg Marten, von Kempis Johannes, Dahdal Suzan, Huynh-Do Uyen, Swiss Systemic Lupus Erythematosus Cohort Study Group (SSCS)
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care.
Riek M, Scherer A, Möller B, Ciurea A, Von Mühlenen I, Gabay C, Kyburz D, Brulhart L, von Kempis J, Mueller R, Hasler P, Strahm T, von Känel S, Zufferey P, Dudler J, Finckh A. Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care. Sci Rep 2023; 13:17776.
18.10.2023Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care.
18.10.2023Sci Rep 2023; 13:17776
Riek Myriam, Scherer Almut, Möller Burkhard, Ciurea Adrian, Von Mühlenen Ines, Gabay Cem, Kyburz Diego, Brulhart Laure, von Kempis Johannes, Mueller Ruediger B, Hasler Paul, Strahm Tanja, von Känel Sabine, Zufferey Pascal, Dudler Jean, Finckh Axel
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Spiera R, Unizony S, Warrington K, Sloane J, Giannelou A, Nivens M, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos G, Marrache F, Patel N, Dasgupta B, SAPHYR Investigators. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. N Engl J Med 2023; 389:1263-1272.
05.10.2023Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
05.10.2023N Engl J Med 2023; 389:1263-1272
Spiera Robert F, Unizony Sebastian, Warrington Kenneth J, Sloane Jennifer, Giannelou Angeliki, Nivens Michael C, Akinlade Bolanle, Wong Wanling, Bhore Rafia, Lin Yong, Buttgereit Frank, Devauchelle-Pensec Valérie, Rubbert-Roth Andrea, Yancopoulos George D, Marrache Frederic, Patel Naimish, Dasgupta Bhaskar, SAPHYR Investigators
TENDINOPATHIEN – eine allgemeininternistische, rheumatologische und sportmedizinische Herausforderung.
Haller C, Noack P, Neumann T. TENDINOPATHIEN – eine allgemeininternistische, rheumatologische und sportmedizinische Herausforderung. - Wie wirksam sind Eigenblut (PRP) Injektionen und wo kann Stosswellentherapie (ESWT) evidenz-basiert angeboten werden?. Der Informierte Arzt 2023; Oktober 2023:29-32.
01.10.2023TENDINOPATHIEN – eine allgemeininternistische, rheumatologische und sportmedizinische Herausforderung.
01.10.2023Der Informierte Arzt 2023; Oktober 2023:29-32
Haller Christoph, Noack Patrik, Neumann Thomas
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis.
Rubenstein E, Maldini C, Vaglio A, Bello F, Bremer J, Moosig F, Bottero P, Pesci A, Sinico R, Grosskreutz J, Feder C, Saadoun D, Trivioli G, Maritati F, Rewerska B, Szczeklik W, Fraticelli P, Guida G, Gregorini G, Moroncini G, Hellmich B, Zwerina J, Resche-Rigon M, Emmi G, Neumann T, Mahr A. Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis. J Rheumatol 2023; 50:1446-1453.
22.09.2023Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis.
22.09.2023J Rheumatol 2023; 50:1446-1453
Rubenstein Emma, Maldini Carla Soledad, Vaglio Augusto, Bello Federica, Bremer Jan Phillip, Moosig Frank, Bottero Paolo, Pesci Alberto, Sinico Renato Alberto, Grosskreutz Julian, Feder Claudia, Saadoun David, Trivioli Giorgio, Maritati Federica, Rewerska Barbara, Szczeklik Wojciech, Fraticelli Paolo, Guida Giuseppe, Gregorini Gina, Moroncini Gianluca, Hellmich Bernhard, Zwerina Jochen, Resche-Rigon Matthieu, Emmi Giacomo, Neumann Thomas, Mahr Alfred
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases.
Finckh A, Ciurea A, Raptis C, Rubbert-Roth A. Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases. J Infect Dis 2023; 228:S13-S23.
04.08.2023Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases.
04.08.2023J Infect Dis 2023; 228:S13-S23
Finckh Axel, Ciurea Adrian, Raptis Catherine E, Rubbert-Roth Andrea
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis.
Alamo B, Moi L, Bajema I, Faurschou M, Flossmann O, Hauser T, Hruskova Z, Jayne D, Luqmani R, Mahr A, Åkesson A, Westman K, EUVAS. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2023; 38:1655-1665.
30.06.2023Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis.
30.06.2023Nephrol Dial Transplant 2023; 38:1655-1665
Alamo Beatriz Sanchez, Moi Laura, Bajema Ingeborg M, Faurschou Mikkel, Flossmann Oliver, Hauser Thomas, Hruskova Zdenka, Jayne David R.W., Luqmani Raashid A, Mahr Alfred, Åkesson Anna, Westman Kerstin, EUVAS
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry.
Micheroli R, Kissling S, Bürki K, Möller B, Finckh A, Nissen M, Exer P, Bräm R, Kyburz D, Rubbert-Roth A, Andor M, Baraliakos X, de Hooge M, Distler O, Scherer A, Ciurea A. Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry. Clin Rheumatol 2023; 42:2377-2385.
08.06.2023Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry.
08.06.2023Clin Rheumatol 2023; 42:2377-2385
Micheroli Raphael, Kissling Seraphina, Bürki Kristina, Möller Burkhard, Finckh Axel, Nissen Michael J, Exer Pascale, Bräm René, Kyburz Diego, Rubbert-Roth Andrea, Andor Michael, Baraliakos Xenofon, de Hooge Manouk, Distler Oliver, Scherer Almut, Ciurea Adrian